Extreme cold good for exercise recovery

Athletes go to great lengths to protect their muscles and recover from exercise-induced muscle damage, but there has been little work to determine what methods are most effective.

Now, a study published in the Dec. 7 issue of the online journal PLoS ONE reports that runners benefit more from whole-body cryotherapy, in which the study participants was exposed to temperatures as cold as -166°F (-110°C), than from exposure to far-infrared radiation or no treatment.

The study, led by Christophe Hausswirth of the National Institute of Sport, Expertise and Performance in Paris, was conducted with nine well trained runners, and each participant tested each recovery method to control for individual differences in muscle damage and recovery.

Overall, the researchers found the whole-body cryotherapy method to be most effective. The first cryotherapy session, conducted one hour after exercise, allowed the runners to recover maximal muscle strength, while the same result took much longer to attain with the other strategies, and three cryotherapy sessions performed over 48 hours post-run accelerated recovery more than the other two methods over the same time period.

According to Dr. Hausswirth, the "whole-body cryotherapy is effective in enhancing post-exercise recovery in well-trained runners, by limiting the maximal force loss and sensations of pain."

Citation: Hausswirth C, Louis J, Bieuzen F, Pournot H, Fournier J, et al. (2011) Effects of Whole-Body Cryotherapy vs. Far-Infrared vs. Passive Modalities on Recovery from Exercise-Induced Muscle Damage in Highly-Trained Runners. PLoS ONE 6(12): e27749. doi:10.1371/journal.pone.0027749

Financial Disclosure: The authors have no support or funding to report.

Competing Interest Statement: The authors have declared that no competing interests exist.

Disclaimer: This press release refers to upcoming articles in PLoS ONE. The releases have been provided by the article authors and/or journal staff. Any opinions expressed in these are the personal views of the contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.

PLoS ONE is the first journal of primary research from all areas of science to employ a combination of peer review and post-publication rating and commenting, to maximize the impact of every report it publishes. PLoS ONE is published by the Public Library of Science (PLoS), the open-access publisher whose goal is to make the world's scientific and medical literature a public resource.

All works published in PLoS ONE are Open Access. Everything is immediately available—to read, download, redistribute, include in databases and otherwise use—without cost to anyone, anywhere, subject only to the condition that the original authors and source are properly attributed. For more information about PLoS ONE relevant to journalists, bloggers and press officers, including details of our press release process and our embargo policy, see the EveryONE blog at http://everyone.plos.org/media.